Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

San Francisco, CA - Heart-failure patients with implanted cardiac resynchronization therapy (CRT) devices are more likely to die if they aren't also taking beta blockers, mostly due to an increased ...

LAKE OSWEGO, Oregon, BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug Administration (FDA) granted approval for its Ilesto 7 implantable ...

Shanghai, China - The first patient implants of the Boston Scientific Corporation COGNIS™ cardiac resynchronization therapy defibrillator (CRT-D) were successfully performed in China’s Zhejiang ...

June 18 (UPI) --People at a risk for heart failure often turn to a defibrillator to remove that threat, but for some patients that's not always the answer, new research shows. For patients with heart ...

The results of COMPANION also demonstrate that CRT or CRT-D, in combination with optimal pharmacologic therapy (OPT), each respectively reduced the rate of death or hospitalization from any cause by ...

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...

DUBLIN, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable ...

Defibrillators, with or without cardiac resynchronization therapy, can reduce the rate of sudden death. However, shocks are unpleasant, often unnecessary, and can damage myocardium or defibrillator ...

Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective. As described in a June notice made ...